Why AbbVie Stock Trounced the Market Today
The positive, post-earnings momentum lifting AbbVie's (NYSE: ABBV) stock price continued on Monday. The veteran healthcare company's shares booked a gain of more than 3% during the trading session. The key reason was a pair of bullish analyst notes on its business. That rise meant the stock easily beat the S&P 500 index, which could only manage a less than 0.1% gain.
Of the two notes, arguably the more impactful was the one BMO Capital's Evan David Seigerman published before market open. The analyst continues to be positive on AbbVie, as he maintained his outperform (buy, in other words) recommendation on the stock and $215 per-share price target.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Not surprisingly, according to reports, Seigerman focused on AbbVie's first-quarter earnings release that was published on Friday. The analyst said that management was continuing to execute well, particularly in relation to important high revenue-generating products Skyrizi and Rinvoq. He pointed out that the unexpectedly high sales of the pair of drugs offset the anticipated declines of Humira.
Seigerman was also cheered by what he considered to be a justifiable raise in per-share earnings guidance by the company. Additionally, the company could gain from favorable foreign exchange movements, in his view.
AbbVie also got a boost from global bank HSBC, which published a somewhat dispiriting update that morning on several prominent healthcare titles.
In its report, the company downgraded several stocks under its coverage. Among other moves, it changed its recommendation on Zepbound maker Eli Lilly to reduce from buy. On the flip side, HSBC flagged several sector names as being buys; among those it considers to be a good value for the money these days is AbbVie.
Before you buy stock in AbbVie, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and AbbVie wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $594,046!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $680,390!*
Now, it's worth noting Stock Advisor's total average return is 872% — a market-crushing outperformance compared to 160% for the S&P 500. Don't miss out on the latest top 10 list, available when you join .
See the 10 stocks »
*Stock Advisor returns as of April 28, 2025
HSBC Holdings is an advertising partner of Motley Fool Money. Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends AbbVie. The Motley Fool recommends HSBC Holdings. The Motley Fool has a disclosure policy.
Why AbbVie Stock Trounced the Market Today was originally published by The Motley Fool
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
The Stock Market Is Rising — and These Hidden Gems Are Staying Cheap
Written by Sneha Nahata at The Motley Fool Canada The S&P/TSX Composite Index, also regarded as the benchmark for the Canadian stock market, has been rising amid easing concerns about a macroeconomic slowdown and interest rate cuts. While many stocks on the TSX have surged, several hidden gems continue to trade at attractive valuations, presenting a compelling opportunity for investors to consider. Against this backdrop, here are a few hidden gems that remain cheap and have solid growth potential. goeasy (TSX:GSY) is one of the top TSX stocks to buy now for its attractive valuation. Despite its impressive track record of solid growth and strong fundamentals, the market is undervaluing this Canadian financial services company. Currently, its shares trade at a next 12-month price-to-earnings (P/E) multiple of around eight, a level that suggests it could be a hidden gem, especially when you consider its potential for sustained earnings growth in the double digits. goeasy operates in the subprime lending space and has proven its ability to thrive in this niche. Over the past five years, the company's sales have grown at a compound annual growth rate (CAGR) of more than 19%. Moreover, its earnings have increased at a CAGR of nearly 26%, outpacing revenue growth. That upward momentum has been reflected in its stock price, which has surged more than 212% over the last five years. Moreover, its solid profitability has driven a consistent increase in its dividend. goeasy has paid a dividend every year for the past 21 years and has increased it for 11 consecutive years, making it a dependable income stock. goeasy's dominance in Canada's subprime lending market, expansion of its consumer loan portfolio, diversified funding sources, and solid underwriting practices position it well to scale rapidly while maintaining profitability. In summary, goeasy offers a compelling mix of value, growth, and income. Its low valuation, strong earnings trajectory, and consistent shareholder returns make it a top pick for creating wealth. Investors seeking a high-quality stock with an attractive valuation could consider WELL Health Technologies (TSX:WELL). This digital healthcare company has been performing well, led by steady demand for its omnichannel patient care services. Moreover, its strategic acquisitions have accelerated its growth and broadened its footprint. Despite its solid operational performance, WELL Health's stock appears significantly undervalued. Currently, it trades at a near-historical low NTM enterprise value-to-sales ratio of just one. This discounted valuation presents a compelling opportunity for investors. WELL Health's growth story shows no signs of slowing down. Besides organic growth, WELL Health will benefit from its acquisitions. The company recently acquired a stake in HEALWELL AI, which will enhance its scale. Moreover, it remains focused on expanding its footprint in Canada, particularly in its patient care and technology services segments. Operationally, WELL Health continues to streamline operations to improve profitability. Moreover, it is strengthening its financial position by reducing debt. Furthermore, WELL Health's focus on minimizing share dilution is a positive aspect. Given its solid growth, improving fundamentals, and attractively low valuation, WELL Health Technologies offers a combination of growth and value. The post The Stock Market Is Rising — and These Hidden Gems Are Staying Cheap appeared first on The Motley Fool Canada. Before you buy stock in goeasy, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and goeasy wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $21,345.77!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*. See the Top Stocks * Returns as of 4/21/25 More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Sneha Nahata has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Corporate Cash Levels Are Starting to Fall
(Bloomberg) -- The latest earnings period brought what might be an early warning sign about credit quality for high-grade US companies. Next Stop: Rancho Cucamonga! Where Public Transit Systems Are Bouncing Back Around the World ICE Moves to DNA-Test Families Targeted for Deportation with New Contract US Housing Agency Vulnerable to Fraud After DOGE Cuts, Documents Warn Trump Said He Fired the National Portrait Gallery Director. She's Still There. Cash levels at blue-chip companies are shrinking, when excluding results from the most-cash-rich corporations. Among members of the S&P 500 that have posted results, cash levels for the latest quarter fell nearly 1% compared with the last three months of 2024. That's according to a Bloomberg News analysis that focuses on non-financial companies with less than $30 billion of cash. The group's cash holdings, now at $1.14 trillion, have broadly been declining since the third quarter of 2023, when they peaked at $1.21 trillion. While companies are still generally performing well, shrinking cash levels can be a sign of business slowing and profits falling. That's a particular concern now as escalating trade wars potentially boost the cost of foreign inputs, weigh on profits, and increase inflation. Bond prices for many US companies leave little room for error. Spreads, or risk premiums, on US high-grade corporate debt averaged just 0.85 percentage point on Friday, the tightest level since March. The average level for the last two decades is closer to 1.5 percentage point. 'It's actually a dangerous position to be in,' said Michael Contopoulos, deputy chief investment officer at Richard Bernstein Advisors. 'If you bring down cash balances and you find yourself having to deal with higher inflation and higher volatility, your debt is going to get punished.' For the biggest cash generators, the story is different. Giants from Meta Platforms Inc. to Microsoft Corp. and Nvidia Corp. generally posted strong earnings this quarter. The top 12 biggest holders of cash saw their holdings rise about 1.4%, to around $756.7 billion. The dozen companies, which also include companies outside of the technology industry like Johnson & Johnson, each have more than $30 billion of cash and marketable securities on their books, and hold in total about 40% of the S&P 500's cash. The biggest companies can distort averages, and by some measures many high-grade companies aren't looking great. Leverage levels, for example, have been better about 80% of the time over the last two decades, a UBS Group AG analysis found. But by other measures companies are still performing well. Investment-grade firms are holding more cash as a share of their assets than they have on average over the past decade, according to data from S&P that analyzed North American companies. It's likely the behavior that has contributed to the declines in cash — such as boosting share buybacks — has reversed this quarter as companies prepare for a slowdown, Bank of America credit strategist Yuri Seliger said. That's why some money managers are stopping short of saying that it's time to prepare for the worst. 'You still want to be positioned in companies that have the ability to weather a range of scenarios, but at the same time, I don't think you want to price your entire portfolio to the worst possible outcome,' said Maulik Bhansali, senior portfolio manager at Allspring Global Investments. If any credit weakness were to hit, it would likely start with smaller companies, and in leveraged finance or even private credit, said Matthew Mish, UBS' head of credit strategy. A close look does show some signs of weakness, at least in the smaller firms. Corporate profits for domestic, non-financial companies declined by about 3% in the first quarter compared to the previous period, Bureau of Economic Analysis data shows. 'The large liquid megacaps have certainly outperformed,' Mish said. 'Under the hood, there certainly is a little bit more weakness.' Week In Review Elon Musk is selling $5 billion of debt to help fund his artificial intelligence startup xAI Corp., the latest in a series of fundraising efforts across his business empire as the billionaire pivots away from politics and returns to running his companies. As part of that bond and loan sale, xAI opened its books to investors, showing the company generated about $52 million of gross revenue in the first quarter, and lost $341 million before interest, tax, depreciation and amortization. The sale may be complicated by a very public feud between Trump and Musk. Hong Kong developer New World Development Co. is sliding deeper into distress after its recent decision to delay interest payments on some bonds, marking the latest flashpoint in a years-long crisis in China's property market. Hedge fund founder George Weiss filed personal bankruptcy months after a federal judge ruled he's liable for more than $100 million in debt his eponymous firm owes Jefferies Financial Group Inc. JPMorgan Chase & Co. is sounding out investors for an almost $2 billion loan for Trucordia, the latest instance of a Wall Street bank refinancing debt that insurers initially secured from private credit firms. A group of Wall Street banks, led by Jefferies Financial Group Inc. and UBS Group AG, have started pre-marketing more than $1 billion of debt to fund Bain Capital's acquisition of restaurant chain operator Sizzling Platter. Owens & Minor, a distributor of medical supplies, canceled its planned purchase of Rotech Healthcare Holdings, sending its bonds on a wild ride. Notes it sold in April, with a 10% coupon and due 2030, dropped, because they can be redeemed at par and had been trading above face value. Many other securities the company had sold rallied. Banks and private credit funds are competing with each other to provide as much as €2.5 billion ($2.9 billion) of debt to insurance broker Diot-Siaci Group. Clearlake Capital-backed Wellness Pet Company snagged fresh financing and completed the first step of a debt deal that involves creditors taking a reduction in the value of the original amount they lent. German autoparts maker ZF Friedrichshafen AG pulled in more than €4.5 billion ($4.6 billion) in orders for a new bond sale, signaling strong investor support for shoring up its finances during a rocky stretch for the sector. Delta Air Lines Inc. sold $2 billion of investment-grade bonds Thursday to help repay a government loan it took out during the pandemic to pay employees. A $2.15 billion leveraged loan has been launched to help fund the planned acquisition of Colonial Enterprises Inc. Bankrupt genetic analysis company 23andMe will hold a second auction for its cache of DNA data with an opening bid of $305 million from a group led by the company's former chief executive officer, Anne Wojcicki. A subsidiary of Sunnova Energy International Inc. filed for bankruptcy in Texas as its parent struggled to convince creditors to give it funding to turn around its business in an out-of-court process. EchoStar Corp., the wireless and pay-TV operator controlled by billionaire Charlie Ergen, has decided to skip interest payments on three bonds after skipping another late last week. On the Move MUFG Securities Americas Inc. has hired two longtime leveraged loan bankers — Adam Hoffman and Roger Gilbert — as it continues to grow that business. Hoffman joins as head of loan trading while Gilbert will serve as head of loan sales. Both previously worked at Macquarie Group Ltd., which shuttered its US debt capital markets arm earlier this year to focus on private credit. Lane42 Investment Partners founder Scott Graves is building out his senior leadership team, hiring former CVC Capital Partners and Oaktree Capital Management employees to add to the asset manager he founded earlier this year. London-based hedge fund Redhedge Asset Management LLP has hired two portfolio managers amid growing US investor interest for European credit. Won Choi joined from Maven Investment Partners to oversee credit opportunities and special situations. Nick Campregher, formerly at ExodusPoint Capital Management, started last month and is focusing on financials. Before moving to the asset management industry, he had spent about a decade at UBS Group AG as a trader and risk manager. --With assistance from Tom Contiliano. Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again The SEC Pinned Its Hack on a Few Hapless Day Traders. The Full Story Is Far More Troubling Is Elon Musk's Political Capital Spent? What Does Musk-Trump Split Mean for a 'Big, Beautiful Bill'? Cuts to US Aid Imperil the World's Largest HIV Treatment Program ©2025 Bloomberg L.P. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
2 TSX Value Stocks to Buy When Everyone Else Is Selling
Written by Adam Othman at The Motley Fool Canada There is always value to be found in the stock market, even when the broader market has a bullish trend. As of this writing, the S&P/TSX Composite Index, which is the benchmark for the Canadian stock market, is nearing new all-time highs. The index is up by almost 17% from its low on April 8, 2025. Typically, savvier investors who can see through the noise of a market sell-off focus on investing when everyone else sells. What if I told you those investors still have opportunities to buy undervalued stocks even when the market is hitting new all-time highs? Year to date, the TSX is up by 5.75%. However, the TSX still has plenty of stocks trailing behind the rest of the market. Today, I will discuss two of them to help you determine whether they might be good candidates to consider long-term winners or stocks to avoid like the plague in your self-directed portfolio. Air Canada (TSX:AC) is a battered and bruised giant in the Canadian airline industry. The $6.05 billion market-cap company is Canada's flag-bearing and largest airline. The company operates domestic, U.S.-Canada transborder flights and several international routes worldwide. Air Canada was one of the top 20 largest airlines worldwide before COVID struck in 2019. Since the pandemic, the stock has failed to recover to better valuations. Despite not operating any flights, AC stock faced considerable cash burn to maintain its fleet, resulting in massive debt for the company without a recovery through operational revenue. Air Canada's most recent earnings report for the first quarter of 2025 saw it report $5.2 billion in revenue. Slightly down from $5.23 billion in the same quarter last year, the airline still generated around $387 million in adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA). The company continues to expand its capacity, and while it may take a long time, there seems to be a recovery on the horizon. Suncor Energy (TSX:SU) is another battered stock but in an entirely different industry. The $61.02 billion market-cap firm based in Calgary is an integrated energy company. It has operations that include oil sands development, production and upgrading, petroleum refining, offshore oil and gas operations, and wholesale distribution networks to retail the end product directly to consumers. The company is also advancing its transition into a lower-emission future. The company trades at roughly 10.29 times trailing earnings, indicating that it might be undervalued right now. As of this writing, Suncor stock trades for $49.71 per share and distributes $0.57 per share each quarter to its shareholders, reflecting a 4.59% annualized dividend yield. It can be a good investment to consider for locking in high-yielding dividends and long-term capital gains. For most investors, investing when the market is going downward does not make sense. Why invest in a bear market when there's nothing but losses everywhere? Smarter investors know how to use those downturns as opportunities to invest in undervalued stocks at a bargain. Despite what some investors might think, there still are opportunities during upticks to invest in bargains. Suncor stock and Air Canada stock might seem very risky investments, and that's because they are. However, the potential to recover to better valuations in the long run is there. If you have a well-balanced portfolio and a higher risk tolerance, these two might be good bets to pay off a few years down the line. The post 2 TSX Value Stocks to Buy When Everyone Else Is Selling appeared first on The Motley Fool Canada. Before you buy stock in Air Canada, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Air Canada wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $21,345.77!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 24 percentage points since 2013*. See the Top Stocks * Returns as of 4/21/25 More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. 2025 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
